Home-Based Pulmonary Rehabilitation for Interstitial Lung Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to gather information on the effectiveness of a home-based pulmonary rehabilitation program with health coaching and tele-monitoring for improving patient-reported respiratory-related quality of life and physical activity in patients with fibrotic Interstitial Lung Diseases (f-ILD).
Who Is on the Research Team?
Teng Moua, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people with a type of lung scarring called fibrotic Interstitial Lung Diseases who feel significantly short of breath. They must have at least 10% lung fibrosis visible on CT scans and be able to understand the study's instructions. It's not for those who've recently done pulmonary rehab, are in hospice care, currently experiencing a flare-up of symptoms, or can't walk due to other health issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a home-based pulmonary rehabilitation program with health coaching and tele-monitoring, including gentle upper body exercises, walking, and breathing practice for 12 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of respiratory-related quality of life and physical activity.
What Are the Treatments Tested in This Trial?
Interventions
- Home-based pulmonary rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Boehringer Ingelheim
Industry Sponsor